{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:15:29Z","timestamp":1783538129891,"version":"3.55.0"},"reference-count":46,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,1,16]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>Platelet-specific lentiviral gene delivery to human hematopoietic stem cells can efficiently introduce FVIII expression in human platelets. Human platelet\u2013derived FVIII can ameliorate the hemophilic phenotype in an immunocompromised hemophilia A mouse model.<\/jats:p>","DOI":"10.1182\/blood-2013-08-520478","type":"journal-article","created":{"date-parts":[[2013,11,23]],"date-time":"2013-11-23T02:06:17Z","timestamp":1385172377000},"page":"395-403","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":46,"title":["Platelet gene therapy corrects the hemophilic phenotype in immunocompromised hemophilia A mice transplanted with genetically manipulated human cord blood stem cells"],"prefix":"10.1182","volume":"123","author":[{"given":"Qizhen","family":"Shi","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Medical College of Wisconsin,"},{"name":"Blood Research Institute, BloodCenter of Wisconsin,"},{"name":"Children\u2019s Research Institute, Children\u2019s Hospital of Wisconsin,"},{"name":"Midwest Athletes Against Childhood Cancer Fund Research Center, Milwaukee, WI; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"Kuether","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical College of Wisconsin,"},{"name":"Blood Research Institute, BloodCenter of Wisconsin,"},{"name":"Children\u2019s Research Institute, Children\u2019s Hospital of Wisconsin,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Blood Research Institute, BloodCenter of Wisconsin,"},{"name":"Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn A.","family":"Schroeder","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical College of Wisconsin,"},{"name":"Blood Research Institute, BloodCenter of Wisconsin,"},{"name":"Children\u2019s Research Institute, Children\u2019s Hospital of Wisconsin,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scot A.","family":"Fahs","sequence":"additional","affiliation":[{"name":"Blood Research Institute, BloodCenter of Wisconsin,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Montgomery","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical College of Wisconsin,"},{"name":"Blood Research Institute, BloodCenter of Wisconsin,"},{"name":"Children\u2019s Research Institute, Children\u2019s Hospital of Wisconsin,"},{"name":"Midwest Athletes Against Childhood Cancer Fund Research Center, Milwaukee, WI; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111817452901800_B1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2141.2006.06087.x","article-title":"The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.","volume":"133","author":"Hay","year":"2006","journal-title":"Br J Haematol"},{"issue":"7","key":"2019111817452901800_B2","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/j.1538-7836.2007.02595.x","article-title":"Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia A.","volume":"5","author":"Gouw","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019111817452901800_B3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2165\/11585340-000000000-00000","article-title":"Current options and new developments in the treatment of haemophilia.","volume":"71","author":"Wong","year":"2011","journal-title":"Drugs"},{"issue":"11","key":"2019111817452901800_B4","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1182\/blood-2006-11-056291","article-title":"Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study.","volume":"109","author":"Gouw","year":"2007","journal-title":"Blood"},{"issue":"2","key":"2019111817452901800_B5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2141.2011.08854.x","article-title":"Parallel use of by-passing agents in haemophilia with inhibitors: a critical review.","volume":"155","author":"Ingerslev","year":"2011","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111817452901800_B6","first-page":"193","article-title":"Treatment of factor VIII inhibitors.","volume":"1","author":"Sultan","year":"1990","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"suppl 1","key":"2019111817452901800_B7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1538-7836.2011.04369.x","article-title":"Gene therapy for haemophilia: a long and winding road.","volume":"9","author":"High","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111817452901800_B8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1089\/hum.2012.088","article-title":"Recent progress in gene therapy for hemophilia.","volume":"23","author":"Chuah","year":"2012","journal-title":"Hum Gene Ther"},{"issue":"3","key":"2019111817452901800_B9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2141.2011.08925.x","article-title":"Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formation.","volume":"156","author":"Scott","year":"2012","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111817452901800_B10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1538-7836.2007.02346.x","article-title":"Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A.","volume":"5","author":"Shi","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2019111817452901800_B11","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1538-7836.2012.04791.x","article-title":"Lentivirus-mediated platelet gene therapy of murine hemophilia A with pre-existing anti-factor VIII immunity.","volume":"10","author":"Kuether","year":"2012","journal-title":"J Thromb Haemost"},{"key":"2019111817452901800_B12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1479-5876-10-30","article-title":"NOD\/scid IL-2Rg(null) mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo.","volume":"10","author":"Spranger","year":"2012","journal-title":"J Transl Med"},{"issue":"2","key":"2019111817452901800_B13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1182\/blood-2010-02-271841","article-title":"Comparison of human cord blood engraftment between immunocompromised mouse strains.","volume":"116","author":"McDermott","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2019111817452901800_B14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A.","volume":"10","author":"Bi","year":"1995","journal-title":"Nat Genet"},{"issue":"11","key":"2019111817452901800_B15","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/j.1538-7836.2004.00961.x","article-title":"Targeting platelet GPIbalpha transgene expression to human megakaryocytes and forming a complete complex with endogenous GPIbbeta and GPIX.","volume":"2","author":"Shi","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2019111817452901800_B16","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1172\/JCI28416","article-title":"Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies.","volume":"116","author":"Shi","year":"2006","journal-title":"J Clin Invest"},{"issue":"7","key":"2019111817452901800_B17","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1182\/blood-2008-02-138214","article-title":"Syngeneic transplantation of hematopoietic stem cells that are genetically modified to express factor VIII in platelets restores hemostasis to hemophilia A mice with preexisting FVIII immunity.","volume":"112","author":"Shi","year":"2008","journal-title":"Blood"},{"issue":"8","key":"2019111817452901800_B18","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1182\/blood-2009-11-255612","article-title":"Factor IX ectopically expressed in platelets can be stored in alpha-granules and corrects the phenotype of hemophilia B mice.","volume":"116","author":"Zhang","year":"2010","journal-title":"Blood"},{"issue":"8","key":"2019111817452901800_B19","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/nprot.2010.87","article-title":"Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing.","volume":"5","author":"Paruzynski","year":"2010","journal-title":"Nat Protoc"},{"issue":"12","key":"2019111817452901800_B20","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1182\/blood-2003-05-1519","article-title":"Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment.","volume":"102","author":"Yarovoi","year":"2003","journal-title":"Blood"},{"issue":"26","key":"2019111817452901800_B21","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1182\/blood-2010-06-293308","article-title":"In vivo efficacy of platelet-delivered, high specific activity factor VIII variants.","volume":"116","author":"Greene","year":"2010","journal-title":"Blood"},{"issue":"11","key":"2019111817452901800_B22","doi-asserted-by":"crossref","first-page":"240a","DOI":"10.1182\/blood.V110.11.781.781","article-title":"Characterizing factor VIII inhibitor resistance of platelet-delivered factor VIII in the treatment of hemophilia A [abstract].","volume":"110","author":"Gewirtz","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2019111817452901800_B23","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1160\/TH08-04-0242","article-title":"Altered bioavailability of platelet-derived factor VIII during thrombocytosis reverses phenotypic efficacy in haemophilic mice.","volume":"100","author":"Damon","year":"2008","journal-title":"Thromb Haemost"},{"issue":"10","key":"2019111817452901800_B24","first-page":"1384","article-title":"Human cell engraftment after busulfan or irradiation conditioning of NOD\/SCID mice.","volume":"91","author":"Robert-Richard","year":"2006","journal-title":"Haematologica"},{"issue":"2","key":"2019111817452901800_B25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10875-010-9478-2","article-title":"Human B cell development and antibody production in humanized NOD\/SCID\/IL-2R\u03b3(null) (NSG) mice conditioned by busulfan.","volume":"31","author":"Choi","year":"2011","journal-title":"J Clin Immunol"},{"issue":"1","key":"2019111817452901800_B26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1634\/stemcells.2008-0583","article-title":"Busulfan produces efficient human cell engraftment in NOD\/LtSz-Scid IL2Rgamma(null) mice.","volume":"27","author":"Hayakawa","year":"2009","journal-title":"Stem Cells"},{"issue":"6","key":"2019111817452901800_B27","doi-asserted-by":"crossref","first-page":"e38491","DOI":"10.1371\/journal.pone.0038491","article-title":"An improved protocol for efficient engraftment in NOD\/LTSZ-SCIDIL-2R\u03b3null mice allows HIV replication and development of anti-HIV immune responses.","volume":"7","author":"Singh","year":"2012","journal-title":"PLoS ONE"},{"issue":"6","key":"2019111817452901800_B28","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood.V97.6.1635","article-title":"Xenotransplantation of immunodeficient mice with mobilized human blood CD34+ cells provides an in vivo model for human megakaryocytopoiesis and platelet production.","volume":"97","author":"Perez","year":"2001","journal-title":"Blood"},{"issue":"2","key":"2019111817452901800_B29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1600-0609.2006.00783.x","article-title":"Efficient assay for evaluating human thrombopoiesis using NOD\/SCID mice transplanted with cord blood CD34+ cells.","volume":"78","author":"Suzuki","year":"2007","journal-title":"Eur J Haematol"},{"issue":"2","key":"2019111817452901800_B30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1634\/stemcells.22-2-135","article-title":"Fast but durable megakaryocyte repopulation and platelet production in NOD\/SCID mice transplanted with ex-vivo expanded human cord blood CD34+ cells.","volume":"22","author":"Bruno","year":"2004","journal-title":"Stem Cells"},{"issue":"24","key":"2019111817452901800_B31","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1182\/blood-2009-02-205989","article-title":"Human platelets produced in nonobese diabetic\/severe combined immunodeficient (NOD\/SCID) mice upon transplantation of human cord blood CD34(+) cells are functionally active in an ex vivo flow model of thrombosis.","volume":"114","author":"Salles","year":"2009","journal-title":"Blood"},{"issue":"8","key":"2019111817452901800_B32","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2012-01-407890","article-title":"Full reconstitution of human platelets in humanized mice after macrophage depletion.","volume":"120","author":"Hu","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2019111817452901800_B33","first-page":"1","article-title":"Breeding of a non-obese, diabetic strain of mice.","volume":"29","author":"Makino","year":"1980","journal-title":"Jikken Dobutsu"},{"issue":"8","key":"2019111817452901800_B34","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.4049\/jimmunol.158.8.3978","article-title":"Initiation of autoimmune diabetes in NOD\/Lt mice is MHC class I-dependent.","volume":"158","author":"Serreze","year":"1997","journal-title":"J Immunol"},{"issue":"12","key":"2019111817452901800_B35","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/ni1527","article-title":"Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells.","volume":"8","author":"Takenaka","year":"2007","journal-title":"Nat Immunol"},{"key":"2019111817452901800_B36","first-page":"197","article-title":"The scid mouse mutant.","volume":"137","author":"Bosma","year":"1988","journal-title":"Curr Top Microbiol Immunol"},{"issue":"9","key":"2019111817452901800_B37","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.4049\/jimmunol.150.9.3817","article-title":"Strain-dependent leakiness of mice with severe combined immune deficiency.","volume":"150","author":"Nonoyama","year":"1993","journal-title":"J Immunol"},{"issue":"1","key":"2019111817452901800_B38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1538\/expanim.50.67","article-title":"Lack of B cell leakiness in BALB\/cA-nu, scid double mutant mice.","volume":"50","author":"Hioki","year":"2001","journal-title":"Exp Anim"},{"issue":"3","key":"2019111817452901800_B39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1006\/clim.2000.4891","article-title":"Immunoglobulin leakiness in scid mice with CD4(+) T-cell-induced chronic colitis.","volume":"96","author":"Brimnes","year":"2000","journal-title":"Clin Immunol"},{"issue":"4","key":"2019111817452901800_B40","first-page":"261","article-title":"B and T cell leakiness in the scid mouse mutant.","volume":"3","author":"Bosma","year":"1992","journal-title":"Immunodefic Rev"},{"issue":"2","key":"2019111817452901800_B41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.blre.2004.05.002","article-title":"Platelet function analysis.","volume":"19","author":"Harrison","year":"2005","journal-title":"Blood Rev"},{"issue":"6","key":"2019111817452901800_B42","first-page":"457","article-title":"Platelet volume is not increased in essential hypertension.","volume":"8","author":"Bath","year":"1994","journal-title":"J Hum Hypertens"},{"issue":"3","key":"2019111817452901800_B43","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/scd.2007.0194","article-title":"Optimized lentiviral transduction of mouse bone marrow-derived mesenchymal stem cells.","volume":"17","author":"Ricks","year":"2008","journal-title":"Stem Cells Dev"},{"issue":"3","key":"2019111817452901800_B44","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ymthe.2005.01.022","article-title":"Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.","volume":"12","author":"Siapati","year":"2005","journal-title":"Mol Ther"},{"issue":"2","key":"2019111817452901800_B45","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1182\/blood-2003-07-2363","article-title":"ABC transporter inhibitors that are substrates enhance lentiviral vector transduction into primitive hematopoietic progenitor cells.","volume":"104","author":"Davis","year":"2004","journal-title":"Blood"},{"issue":"16","key":"2019111817452901800_B46","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2010-03-272419","article-title":"Targeting FVIII expression to endothelial cells regenerates a releasable pool of FVIII and restores hemostasis in a mouse model of hemophilia A.","volume":"116","author":"Shi","year":"2010","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/3\/395\/1377263\/395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/3\/395\/1377263\/395.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T07:39:59Z","timestamp":1716190799000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/123\/3\/395\/32298\/Platelet-gene-therapy-corrects-the-hemophilic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,16]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,1,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2013-08-520478","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,16]]}}}